NCT00280865 · Interventional trial
GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes
Overall registry status Completed
Phase 2
Conditions Type 2 Diabetes
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory